Long-term outcome after radiotherapy in patients with atypical and malignant meningiomas--clinical results in 85 patients treated in a single institution leading to optimized guidelines for early radiation therapy.
暂无分享,去创建一个
A. von Deimling | J. Debus | C. Hartmann | S. Combs | T. Welzel | D. Habermehl | S. Adeberg | S. Rieken
[1] A. von Deimling,et al. Improved correlation of the neuropathologic classification according to adapted world health organization classification and outcome after radiotherapy in patients with atypical and anaplastic meningiomas. , 2011, International journal of radiation oncology, biology, physics.
[2] Steven D Chang,et al. Cyberknife Stereotactic Radiosurgery for Treatment of Atypical (Who Grade II) Cranial Meningiomas , 2010, Neurosurgery.
[3] A. von Deimling,et al. Carbon ion radiation therapy for high-risk meningiomas. , 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[4] Pascal Pommier,et al. Combined proton and photon conformal radiotherapy for intracranial atypical and malignant meningioma. , 2009, International journal of radiation oncology, biology, physics.
[5] G. Barnett,et al. Long-term experience with World Health Organization grade III (malignant) meningiomas at a single institution. , 2009, International journal of radiation oncology, biology, physics.
[6] W. Curry,et al. LONG‐TERM RECURRENCE RATES OF ATYPICAL MENINGIOMAS AFTER GROSS TOTAL RESECTION WITH OR WITHOUT POSTOPERATIVE ADJUVANT RADIATION , 2009, Neurosurgery.
[7] J. Reijneveld,et al. Source (or Part of the following Source): Type Article Title Late Neurocognitive Sequelae in Patients with Who Grade I Meningioma Author(s) , 2022 .
[8] B. Guthrie,et al. Hitting a moving target: evolution of a treatment paradigm for atypical meningiomas amid changing diagnostic criteria. , 2008, Neurosurgical focus.
[9] R. Mirimanoff,et al. Atypical and malignant meningioma: outcome and prognostic factors in 119 irradiated patients. A multicenter, retrospective study of the Rare Cancer Network. , 2007, International journal of radiation oncology, biology, physics.
[10] Y. Chung,et al. Atypical and anaplastic meningiomas: prognostic implications of clinicopathological features , 2007, Journal of Neurology, Neurosurgery, and Psychiatry.
[11] W. Schlegel,et al. Intensity-modulated radiotherapy for complex-shaped meningioma of the skull base: long-term experience of a single institution. , 2007, International journal of radiation oncology, biology, physics.
[12] J. Reijneveld,et al. Differential effect of surgery and radiotherapy on neurocognitive functioning and health-related quality of life in WHO grade I meningioma patients , 2007, Journal of Neuro-Oncology.
[13] D. Macarthur,et al. Atypical meningiomas: WHO moved the goalposts? , 2007, British journal of neurosurgery.
[14] U. Sure,et al. Clinicopathologic Features of Aggressive Meningioma Emphasizing the Role of Radiotherapy in Treatment , 2006, Strahlentherapie und Onkologie.
[15] W. Schlegel,et al. Fractionated Stereotactic Radiation Therapy in the Management of Benign Cavernous Sinus Meningiomas , 2006, Strahlentherapie und Onkologie.
[16] U. Haberkorn,et al. Improved target volume definition for fractionated stereotactic radiotherapy in patients with intracranial meningiomas by correlation of CT, MRI, and [68Ga]-DOTATOC-PET. , 2006, International journal of radiation oncology, biology, physics.
[17] J. Schramm,et al. Interinstitutional variance of postoperative radiotherapy and follow up for meningiomas in Germany: impact of changes of the WHO classification , 2005, Journal of Neurology, Neurosurgery & Psychiatry.
[18] I. Whittle,et al. The accuracy of meningioma grading: a 10‐year retrospective audit , 2005, Neuropathology and applied neurobiology.
[19] W. Schlegel,et al. Fractionated stereotactic radiotherapy in patients with benign or atypical intracranial meningioma: long-term experience and prognostic factors. , 2005, International journal of radiation oncology, biology, physics.
[20] W. Mendenhall,et al. Pushing the Limits of Radiotherapy for Atypical and Malignant Meningioma , 2005, American journal of clinical oncology.
[21] M. McDermott,et al. Surgical Resection and Permanent Brachytherapy for Recurrent Atypical and Malignant Meningioma , 2004, Neurosurgery.
[22] R. Ojemann,et al. Management of Atypical and Malignant Meningiomas: Role of High-dose, 3D-conformal Radiation Therapy , 2000, Journal of Neuro-Oncology.
[23] M. Bondy,et al. Epidemiology and etiology of intracranial meningiomas: A review , 1996, Journal of Neuro-Oncology.
[24] B. Rhein,et al. Intensity modulated radiotherapy (IMRT) for recurrent, residual, or untreated skull-base meningiomas: preliminary clinical experience. , 2003, International journal of radiation oncology, biology, physics.
[25] W. Yung,et al. PATHOLOGY AND GENETICS OF TUMOURS OF THE NERVOUS SYSTEM , 2002 .
[26] J. Debus,et al. High efficacy of fractionated stereotactic radiotherapy of large base-of-skull meningiomas: long-term results. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[27] M. Berger,et al. Radiosurgery for malignant meningioma: results in 22 patients. , 2000, Journal of neurosurgery.
[28] W. Simpson,et al. Radiotherapy for atypical or malignant intracranial meningioma. , 1996, International journal of radiation oncology, biology, physics.
[29] B. Scheithauer,et al. Histological Typing of Tumours of the Central Nervous System , 1993, World Health Organization.
[30] O. G. Dodge,et al. Histological Typing of tumours of the Central Nervous System , 1981, British Journal of Cancer.